Hikma has acquired the FDA-approved Abbreviated New Drug Application for trametinib tablets from Novugen. Hikma also has entered into a commercial agreement with Novugen where Hikma will be ...

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it will be "agile" in its response to the evolving tariff backdrop as it reiterated its full-year outlook. In a trading statement ahead ...

LONDON, April 17, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug ...

Hikma Pharmaceuticals (OTCPK:HKMPF) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets, a cancer treatment medication, from ...